Swing setup research
ALOKINDS
Latest close: ₹8.22 · Data through 2026-10-27
Total score
55/100
Entry reference
₹8.22
Stop loss
₹7.55
Target
₹9.47
Risk / reward
1:1.87
These are rule-calculated reference levels from the report, not live quotes or instructions to trade. Recheck the market price before using them.
Score breakdown
Technical 55/80 · Fundamentals 0/20
Trend10/20
Relative strength15/15
Setup20/20
Volume3/15
Risk / reward7/10
Fundamentals0/20
Fundamental metrics
Source: Upstox Company Fundamentals API
Return on equity (ROE)3.46%
Return on capital employed (ROCE)-3.72%
Revenue growth-0.81%
P/E ratio-5.38x
P/B ratio-0.26x
Debt / equityNot available
Fundamentals updated: 27/10/2026
Why it scored this way
- ✓Price above 20 EMA
- ✓20-day relative strength 18.1%
- ✓Price near 20 EMA in an uptrend
Data limitations
- Debt/equity is not provided by Upstox key-ratios API
Fundamental data notes: Debt/equity is not provided by Upstox key-ratios API
Recent market history
Choose 3 or 6 months to compare price action and volume. The table below keeps the latest 10 sessions.
Showing 63 of 278 available sessions
Close at/above openClose below openVolume
Hover over a candle for open, high, low, close and volume. The chart uses available historical data only; the 6-month view may show fewer sessions if history is incomplete.
View exact daily figures
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2026-10-27 | 8.15 | 8.27 | 8.07 | 8.22 | 71,20,969 |
| 2026-10-26 | 8.01 | 8.24 | 7.91 | 8.17 | 93,78,569 |
| 2026-10-25 | 8.34 | 8.34 | 7.81 | 8.09 | 1,60,60,918 |
| 2026-10-23 | 8.34 | 8.34 | 7.81 | 8.09 | 1,60,60,918 |
| 2026-10-22 | 8 | 8.39 | 7.97 | 8.13 | 1,33,38,288 |
| 2026-10-21 | 8.18 | 8.3 | 7.9 | 8.14 | 1,49,90,509 |
| 2026-10-20 | 8.68 | 8.68 | 8.1 | 8.17 | 1,28,48,593 |
| 2026-10-19 | 8.68 | 8.68 | 8.1 | 8.17 | 1,28,48,593 |
| 2026-10-18 | 8.3 | 8.78 | 8.3 | 8.5 | 1,79,99,921 |
| 2026-10-16 | 8.3 | 8.78 | 8.3 | 8.5 | 1,79,99,921 |
Research tool — not a stock recommendation. This page presents rule-based screening results for education and research. It is not investment advice, a buy/sell recommendation, or a guarantee of returns. Metrics may be incomplete or stale. Verify information independently and assess your own risk.